Is insomnia best categorized as a symptom or a disease?

被引:34
作者
Billiard, M
Bentley, A
机构
[1] Hop Gui De Chauliac, Fac Med, F-34295 Montpellier 5, France
[2] Univ Witwatersrand, Sch Physiol, Johannesburg, South Africa
关键词
disorder; disease symptom; insomnia; classification;
D O I
10.1016/S1389-9457(04)90006-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Insomnia, defined by difficulty falling asleep or remaining asleep, early morning awakening and/or non-restorative sleep, and daytime consequences, is an important public health issue with a significant negative impact on individuals' physical and social performance, ability to work and quality of life, as well as on society as a whole. Chronic insomnia warrants treatment in the majority of cases, but it is often under-treated. Primary insomnia occurs independently of other factors, and is possibly related to a general psychophysiologic hyperarousal. Other types of insomnia occur in association with various conditions such as psychiatric disorders, medical disorders (e.g., chronic pain, respiratory dysfunction and movement disorders), circadian rhythm disorders and medication or substance use. These types of insomnia are diagnosed more frequently in the clinic. As a result, insomnia is traditionally viewed and treated as a symptom rather than a disease, with the majority of therapies aimed at resolving underlying medical factors. However, it is important to clearly establish whether co-morbidities are causative for or simply co-exist with insomnia, in order to recommend the most appropriate treatment and optimize treatment outcomes. Difficulties still arise when categorizing insomnia subtypes. Here, we highlight some of the major challenges for future research in classifying both primary insomnia and insomnia related to or associated with various conditions, and their relevance to primary care. (C) 2004 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:S35 / S40
页数:6
相关论文
共 62 条
[21]   Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia [J].
Hajak, G ;
Rodenbeck, A ;
Staedt, J ;
Bandelow, B ;
Huether, G ;
Ruther, E .
JOURNAL OF PINEAL RESEARCH, 1995, 19 (03) :116-122
[22]  
HAJAK G, 2000, SLEEP S3, V23, P854
[23]   Insomnia, health-related quality of life and healthcare resource consumption - A study of managed-care organisation enrollees [J].
Hatoum, HT ;
Kong, SX ;
Kania, CM ;
Wong, JM ;
Mendelson, WB .
PHARMACOECONOMICS, 1998, 14 (06) :629-637
[24]  
HOHAGEN F, 1993, ARCH PSYCHIAT CLIN N, V242, P325
[25]  
Holbrook AM, 2000, CAN MED ASSOC J, V162, P216
[26]   Impact of insomnia on health-related quality of life [J].
Idzikowski, C .
PHARMACOECONOMICS, 1996, 10 :15-24
[27]   MUSCLE PAIN, DYSKINESIA, AND SLEEP [J].
LAVIGNE, GJ ;
VELLYMIGUEL, AM ;
MONTPLAISIR, J .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1991, 69 (05) :678-682
[28]   SF-36:: Evaluation of quality of life in severe and mild insomniacs compared with good sleepers [J].
Léger, D ;
Scheuermaier, K ;
Philip, P ;
Paillard, M ;
Guilleminault, C .
PSYCHOSOMATIC MEDICINE, 2001, 63 (01) :49-55
[29]  
LEGER D, 1999, SLEEP S2, V22, P349
[30]   THE EFFECTS OF EXOGENOUS MELATONIN ON THE TOTAL SLEEP TIME AND DAYTIME ALERTNESS OF CHRONIC INSOMNIACS - A PRELIMINARY-STUDY [J].
MACFARLANE, JG ;
CLEGHORN, JM ;
BROWN, GM ;
STREINER, DL .
BIOLOGICAL PSYCHIATRY, 1991, 30 (04) :371-376